Accelerate Diagnostics (AXDX)
(Delayed Data from NSDQ)
$1.78 USD
+0.06 (3.49%)
Updated Aug 23, 2024 03:59 PM ET
After-Market: $1.75 -0.03 (-1.69%) 7:58 PM ET
2-Buy of 5 2
F Value A Growth B Momentum C VGM
Price, Consensus and EPS Surprise
AXDX 1.78 +0.06(3.49%)
Will AXDX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for AXDX based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for AXDX
Accelerate Diagnostics (AXDX) Completes WAVE Pre-Clinical Trial
Accelerate Diagnostics (AXDX) Reports Q2 Loss, Misses Revenue Estimates
AXDX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Silk Road Medical (SILK) Reports Q2 Loss, Tops Revenue Estimates
InspireMD, Inc. (NSPR) Reports Q2 Loss, Misses Revenue Estimates
Delcath Systems, Inc. (DCTH) Reports Q2 Loss, Tops Revenue Estimates
Other News for AXDX
US settles with billionaire Carl Icahn for using company to secure personal loans worth billions
Accelerate Diagnostics, Inc. (AXDX) Q2 2024 Earnings Call Transcript
AXDX Stock Earnings: Accelerate Diagnostics Beats EPS, Misses Revenue for Q2 2024
Accelerate Diagnostics: Q2 Earnings Snapshot
Accelerate Diagnostics Reports Second Quarter 2024 Financial Results